TrialCancer research and treatment2021

The Pattern of Time to Onset and Resolution of Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors in Cancer: A Pooled Analysis of 23 Clinical Trials and 8,436 Patients.

Si-Qi Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.